Model Medicines
Signal active
Organization
Contact Information
Overview
Model Medicines uses human expertise and AI to accelerate the development of life-changing drugs at scale. Model Medicines harnesses AI and ML with its ActivPred AI Drug Discovery Platform to discover drugs that may be repositioned to serve as therapeutics to treat patients suffering from humankind’s toughest diseases.
The drugs that Model Medicines discovers can enter clinical trials in as little as several months.
About
Industries
Biotechnology, Artificial Intelligence (AI), Machine Learning, Pharmaceutical, Medical
Founded
2019
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Model Medicines headquartered in United States, North America, operates in the Biotechnology, Artificial Intelligence (AI), Machine Learning, Pharmaceutical, Medical sector. The company focuses on Biotechnology and has secured $82.0M in funding across 20 round(s). With a team of 11-50 employees, Model Medicines is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Model Medicines, raised $4.1M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
7
Lead Investors
0
Total Funding Amount
$4.1M
Details
1
Model Medicines has raised a total of $4.1M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Seed | 4.1M |
Investors
Model Medicines is funded by 8 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Andrew Kalmar | - | FUNDING ROUND - Andrew Kalmar | 4.1M |
| Irving Investors | - | FUNDING ROUND - Irving Investors | 4.1M |
| Carter Comstock | - | FUNDING ROUND - Carter Comstock | 4.1M |
| Model Medicines | - | FUNDING ROUND - Model Medicines | 4.1M |
Recent Activity
There is no recent news or activity for this profile.